Printer Friendly
The Free Library
14,633,648 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Onset Therapeutics Announces Agreement with Granard Pharmaceutical for Trade Sales & Marketing.


WOONSOCKET, R.I. -- Onset Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, a specialty pharmaceutical company that focuses on the development and commercialization of innovative, patent protected topical topical /top·i·cal/ (top´i-k'l) pertaining to a particular area, as a topical antiinfective applied to a certain area of the skin and affecting only the area to which it is applied.

top·i·cal
adj.
 products for skin and wound related disorders, announced today that they have signed an Agreement with Granard Pharmaceutical Sales and Marketing to provide trade sales & marketing services. Granard will be responsible for contracting with pharmaceutical wholesalers, retail pharmacy chains, and mail order pharmacies and implementing product related promotional programs with this customer segment.

With significant development capabilities that include formulation development through GMP GMP (guanosine monophosphate): see guanine.  manufacturing, Onset expects to market numerous topical products within the wound care and dermatology dermatology (dûrmətŏl`əjē), branch of medicine concerned with diagnosis and treatment of diseases and disorders of the skin.  markets in 2006. In addition, the company has a full pipeline of products that it intends to launch over the next 3 years. The Agreement is for Granard to represent multiple Onset products in addition to the recently launched Optase(TM) for the promotion of wound healing wound healing Physiology The repair of a wound Steps Inflammation, repair and closure, remodeling, final healing; repair of incisions may be either simple–'clean' wounds with little loss of tissue heal by 'primary intention', or 'dirty' wounds heal by .

"After thoroughly considering all options for bringing our products to the market, including an extensive search of trade sales & marketing companies, we chose Granard because of their solid record of success in launching products into the trade distribution channel. As we launch Optase(TM) together, we continue to be impressed im·press 1  
tr.v. im·pressed, im·press·ing, im·press·es
1. To affect strongly, often favorably:
 with their deep knowledge and relationships in this sector," stated Michael Heffernan Michael Heffernan (3 April, 1885 – 21 November, 1970) was an Irish Farmers' Party politician. He was first elected to Dáil Éireann in 1927 as a TD for Tipperary. He served as Parliamentary Secretary to the Minister for Posts and Telegraphs from 1927 to 1932. , President of Onset Therapeutics.

"We are excited to be working with Onset on the launch of Optase(TM) and are looking forward to working with them on many additional products that are in their pipeline," stated Steve Flood, President of Granard. "Onset's strategy to develop products that specifically address some of the limitations inherent in currently available formulations allows Granard to offer highly differentiated products to our trade partners."

About Onset Therapeutics

Onset Therapeutics is a privately held specialty pharmaceutical company focusing on the development and commercialization of novel, patent protected topical products for the treatment of wounds and skin disorders. For more information, please visit the company's website at www.onsettx.com

About Granard Pharmaceutical

Granard Pharmaceutical is a full-service trade sales and marketing company that is dedicated to launching brands & generic products, growing existing product sales, and patent expiration EXPIRATION. Cessation; end. As, the expiration of, a lease, of a contract, or statute.
     2. In general, the expiration of a contract puts an end to all the engagements of the parties, except to those which arise from the non- fulfillment of obligations created
 transitions for pharmaceutical manufacturers. The company offers complete turn-key services and provides customized programs to pharmaceutical and bio-tech manufacturers. For more information, please visit the company's website at www.granardrx.com
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 25, 2006
Words:379
Previous Article:Orange Romania Deploys InStranet's Multi-Channel Knowledge Applications to Improve Customer Satisfaction.
Next Article:Optical Internetworking Forum Approves TDM-Protocol Implementation Agreement; Group Begins Migration of Technical Work Following NPF Merger.
Topics:



Related Articles
Micro Laboratories Inc. Announces the Signing of a Three Year Contract With Granard Pharmaceutical.
Micro Laboratories Acquires St. John's Wort Spray.
SHIRES' OPTION FOR RIGHTS TO EMITASOL EXPIRES.
EXONHIT INITIATES PHASE II CLINICAL TRIAL FOR EHT 0201.
Aegis Therapeutics' Intravail(TM) Drug Delivery Technology Gaining Acceptance.
Onset Therapeutics Announces Company Launch; Company to Focus on Development and Commercialization of Products for Wound Care and Dermatology.
ECHO Strengthens Its Management Team.
ChemGenex Discovery Highlighted At International Diabetes Conference.
Rohto Pharmaceutical, Dynamics Therapeutics Enter into Licensing Agreement for Anti-aging Ingredient Supplamine.
Onset Therapeutics Announces Agreement with Managed Healthcare Associates (MHA); Optase(TM) is the first product subject to the Agreement.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles